Activity value 76china Buyer&Supplier,Last transaction date:
2026-03-31
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for hubei nongyuanpharmaceutical co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 74 transactions, with a transaction quantity of 1414488.38 and a transaction weight of 393400.
Product description
(PHARMACEUTICAL ALLOPATHIC RAW MATERIAL OF PHARMA GRADE)METRONIDAZOLE BP...QTY:1500 KGS...BATCH NO:0182512054,0182512148...MFG DT:05/12/2025,17/12/2025...EXP DT:11/2029,11/2029...PACKED IN 25 KG EACH NET WT DRUM
Expand
Product description
Nguyên liệu dược: METRONIDAZOLE, tiêu chuẩn:BP2025, dạng bột màu vàng nhạt, dùng để sản xuất thuốc, số lô:0182512059, 25kg/thùng, NSX:06.12.2025, HSD: 11.2029, hàng mới100%
Expand
Trade date
2026/02/27
B/L No.
——
Suppliers
hubei nongyuanpharmaceutical co.ltd.
Buyers
m/s stanley pharmaceuticals (pvt) ltd
5aarti drugs ltd.
indiasupplier,they trade on 2023-06-28
892.17%
>
+View All
Products
Total 184
ProductsTransactionsPerDetail
metronidazole 23724.48%>
pharmaceutical raw material 22923.66%>
glyoxylic acid 18519.11%>
pla 14915.39%>
metronidazole bp 13614.05%>
+View All
Hscode rank
Total 74
HSCode NameTransactionsPerDetail
HS 2933290044746.18%>
HS 2933292010610.95%>
HS 2918309010110.43%>
HS 29121930717.33%>
HS 29339990535.48%>
+View All
Trading Area
Total 19
AreaTransactionsPerDetail
pakistan171441.77%>
india167240.75%>
vietnam1483.61%>
united states1363.31%>
bangladesh1353.29%>
+View All
Port statistics
Total 28
Port NameTransactionsPerDetail
shanghai69817.01%>
wuhan932.27%>
singapore411.00%>
innsa290.71%>
shanghai cn260.63%>
+View All
hubei nongyuanpharmaceutical co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as metronidazole,pharmaceutical raw material,glyoxylic acid.
According to the 52wmb.com global trade database, as of 2026-03-31, the company has completed 4103 international trades,
with its main trading regions covering pakistan,india,vietnam etc.
The core products include HS29332900,HS29332920,HS29183090 etc,
often transported via shanghai,port wuhan, port singapore etc,
and its main trading partners are aarti drugs limited,sanofi aventis usa inc.,j b chemicals pharmaceuticals ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on hubei nongyuanpharmaceutical co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.